Anti-depressant-like activity of a novel serotonin type-3 (5-HT 3) receptor antagonist in rodent models of depression

Indian Journal of Experimental Biology

Volumn 49, Issue 8, 2011, Pages 619-626

  Gupta, Deepali ^a   Devadoss, Thangaraj ^a   Bhatt, Shvetank ^a   Gautam, Baldev ^a   Jindal, Ankur ^a   Pandey, Dilip ^a   Mahesh, Radhakrishnan ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

5 HT 3; Antagonist; Anti depressant like effect; Depression; Forced swim test; Quinoxalin 2 carboxamide; Serotonin

Indexed keywords

ANTIDEPRESSANT AGENT; N CYCLOHEXYL 3 METHOXYQUINOXALIN 2 CARBOXAMIDE; N-CYCLOHEXYL-3-METHOXYQUINOXALIN-2-CARBOXAMIDE; QUINOXALINE DERIVATIVE; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DEPRESSION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; FEMALE; IMMOBILIZATION; MALE; METABOLISM; MOTOR ACTIVITY; MOUSE; RAT; SWIMMING; WISTAR RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HINDLIMB SUSPENSION; MALE; MICE; MOLECULAR STRUCTURE; MOTOR ACTIVITY; QUINOXALINES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS; SWIMMING;

MUS; RATTUS; RODENTIA;

EID: 80052556798     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Paul E H & Charles B N, Advances in the treatment of depression, Neurotherapeutics, 3 (2006) 42.
2. Rajkumar R & Mahesh R, The auspicious role of the 5-HT3 receptor in depression: A probable neuronal Target, J Pyschopharmcol, 24 (2010) 455.
3. Delbende C, Contesse V, Mocaer E, Kamoun A & Vaudry H, The novel anti-depressant, tianeptine, reduces stress-evoked stimulation of the hypothalamo-pituitary-adrenal axis, Eur J Pharmacol, 202 (1991) 391.
4. Lu XY, Kim CS, Frazer A & Zhang W, Leptin: A potential novel anti-depressant, Proc Natl Acad Sci U S A, 103 (2006) 1593.
5. Kehr W, Debus G & Ruth N, Effects of Rolipam: A novel anti-depressant: on monoamine metabolism in rat brain, J Neural Transm, 63 (1985) 1.
6. Eley TC, Behavioural genetics as a tool for developmental psychology: Anxiety and depression in children and adolescents, Clin Child Fam Psychol Rev, 2 (1999) 21.
7. Rajkumar R & Mahesh R, Assessing the neuronal serotonergic target-based anti-depressant stratagem: impact of in vivo interaction studies and knock out models, Curr Neuropharmacol, 6 (2008) 215.
8. Hoyer D, Honnon JP & Martin GR, Molecular, pharmacological and functional diversity of 5-HT receptors, Pharmacol Biochem Behav, 71 (2002) 533.
9. Vanpraag HM, Can stress cause depression, Prog Neuropsycopharmacol Biol Psychiatry, 28 (2004) 891.
10. Eisensamer B, Rammes G, Gimpl G, Shapa M, Ferrari U, Hapfelmeier G, Bondy B, Parsons C, Gilling K, Zieglgansberger W, Holsboer F & Rupprecht R, Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor, Mol Psychiatry, 8 (2003) 994.
11. Artigas F, Romero L, de Montigny C & Blier P, Acceleration of the effect of selected anti-depressant drugs in major depression by 5-HT1A antagonists, Trends Neurosci, 19 (1996) 378.
12. Silvam R, Valle JR & Picarelli ZP, A pharmacological analysis of the mode of action of serotonin (5-HT) upon the guinea-pig ileum, Br J Pharmacol, 8 (1953) 378.
13. Waeber C, Dixon K, Hoyer D & Palacios JM, Localisation by autoradiography of neuronal 5-HT3 receptors in the mouse CNS, Eur J Pharmacol, 151 (1988) 351.
14. Srivastava SK, Anti-depressant activity of ondansetron, a 5- HT3, antagonist, Indian J Pharmacol, 30 (1998) 411.
15. Martin P, Gozlan H & Puech AJ, 5-HT3 receptor antagonists reverse helpless behaviour in rats, Eur J Pharmacol, 212 (1992) 73.
16. Singh JN, Gupta R & Deshpande SB, Ptychodiscus brevis toxin-induced depression of spinal reflexes involves 5-HT via 5-HT3 receptors modulated by NMDA receptor, Neurosci Lett, 409 (2006) 70.
17. Fan P, Effects of anti-depressants on the inward current mediated by 5-HT3 receptors in rat nodose ganglion neurons, Br J Pharmacol, 112 (1994) 741.
18. Gibbs IS, Heald A, Jacobson H, Wadke D & Weliky I, Physical characterization and activity in vivo of polymorphicforms of 7-chloro-5, 11-dihydrodibenz[b, e][1,4]oxazepine- 5-carboxamide, a potential tricyclic anti-depressant, J Pharm Sci, 65 (1976) 1380.
19. Hadizadeh F, Hosseinzadeh H, Motamed-Shariaty Sadat V, Seifi M & Kazemi S, Synthesis and anti-depressant activity of N-substituted imidazole-5-carboxamides in forced swimming test model, Iran J Pharm Res, 7 (2008) 29.
20. Pessoa Mahana H, Rodrigo AR, Ramiro AM, Claudio SB & Pessoa-Mahana C David, Synthesis of benzo[b]thiophene carboxamides connected to 4-arylpiperazines through a benzylic spacer: potential ligands with 5-HT1a binding affinity, Synth Commun, 37 (2007) 3559.
21. Steru L, Chermat R, Thierry B, & Simon P, The tail suspension test: A new method for screening antidepressants in mice, Psycopharmacol (Berl), 85 (1985) 367.
22. O'Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME & Lucki I, Depletion of serotonin and catecholamines block the acute behavioural response to different classes of antidepressant drugs in the mouse tail suspension test, Psychopharmacology (Berl), 192 (2007) 357.
23. Dhingra D & Goyal PK, Inhibition of MAO and GABA: Probable mechanisms for anti-depressant-like activity of Nardostachys jatamansi dc in mice, Indian J Exp Biol, 46 (2008) 212.
24. Porsolt RD, Bertin A & Jalfre M, Behavioural despair in mice: A primary screening test for anti-depressants, Arch. Int. Pharmacodyn. Ther, 229 (1977) 327.
25. Demouliere BP, Chenu F & Bourin M, Forced swimming test in mice: A review of anti-depressant activity, Psychopharmacology (Berl), 177 (2005) 245.
26. Albel EL & Bilitzke PJ, A possible alarm substance in the force swimming test, Physiol Behav, 48 (1990) 233.
27. Devadoss T, Pandey DK, Mahesh R & Yadav SK, Effect of acute and chronic treatment with QCF-3 (4-benzylpiperazin- 1-yl) (quinoxalin-2-yl) methanone, a novel 5-HT3 receptor antagonist, in animal models of depression, Pharmacol Rep, 62 (2010) 245.
28. Pandey DK, Rajkumar R, Mahesh R & Radha R, Depressant-like effects of Parthenolide in a rodent behavioural anti-depressant test battery, J Pharm Pharmacol, 60 (2008) 1643.
29. Boissier JR & Simon P, Action of caffeine on the spontaneous motility of the mouse, Arch. Int. Pharmacodyn. Ther, 158 (1965) 212.
30. Velraj M, Vijayalakshmi A, Jayakumari S, Ramamoorthy S, Ravichandiran V & Srikanth J, Anti-depressant activity of the ethanolic extract of Albizzia lebbeck (linn) bark in animal models of depression, Drug Invention Today, 1 (2009) 112.
31. Evans R W & Taylor F R, "Natural" or alternative medications for migraine prevention, Headache, 46 (2006) 1012.
32. Marles RJ, Kaminski J, Arnason JT, Pazos SL, Heptinstall S, Fischer NH, Crompton CW, Kindack DG & Awang DV, A bioassay for inhibition of serotonin release from bovine platelets, J Nat Prod, 55 (1992) 1044.
33. Redrobe JP & Bourin M, Partial role of 5-HT3, and 5-HT2, receptors in the activity of anti-depressants in the mouse forced swimming test, Eur J Pharmacol, 325 (1997) 129.
34. Kurkin VA, Dubishchev AV, Ezhkov VN, Titova IN & Avdeeva EV, Anti-depressant activity of some phytopharmaceuticals and phenylpropanoids, Pharm Chem J, 40 (2006) 615.
35. Albert N & Beck AT, Incidence of depression in early adolescence: A preliminary study, J Youth and Adolesc, 4 (1975) 301.
36. Teja JS & Narang RL, Pattern of incidence of depression in India, Indian J Psychiatry, 12 (1970) 33.
37. Boissier JR & Simon P, Action of caffeine on the spontaneous motility of the mouse, Arch Int Pharmacodyn Ther, 158 (1965) 212.
38. Cryan JF, Valentino RJ & Lucki I, Assessing substrates underlying the behavioural effects of anti-depressants using the modified rat forced swimming test, Neurosci Biobehav Rev, 9 (2005) 547.
39. Borsini F & Meli A, Is the forced swimming test a suitable model for revealing anti-depressant activity? Psychopharmacology (Berl), 94 (1988) 147.
40. Porras G, De Deurwaerdère P, Moison D & Spampinato U, Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum, Eur J Neurosci, 17 (2003) 771.
41. Kilpatrick GJ, Butler A, Ireland SJ, Michel AD & Tyers MB, Affinities of 5-HT uptake inhibitors for 5-HT, receptors in both binding and functional studies, Br J Pharmacol, 98 (1989) 859.
42. Englert LF, Ho BT & Taylor D, The effects of (-)-a9-tetrahydrocannabinol on reserpine-induced hypothermia in rats, Br J Pharmac, 49 (1973) 243.